Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Morgan

Showing results (121-130 of 297) with videos related to

Pageof 30
Sort By:
Neuropharmacology|January 18, 2018
Ketamine for the treatment of addiction: Evidence and potential mechanismsI Ivan Ezquerra-Romano, W Lawn, E Krupitsky, et al.
Lancet (London, England)|June 25, 1988
Deletions of muscle mitochondrial DNAI J Holt, J M Cooper, J A Morgan-Hughes, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|March 1, 1997
Nemaline myopathy: an unusual cause of ophthalmoparesisR A Wright, G T Plant, D N Landon, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 30, 2010
Cannabidiol attenuates the appetitive effects of Delta 9-tetrahydrocannabinol in humans smoking their chosen cannabisCelia J A Morgan, Tom P Freeman, Gráinne L Schafer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 7, 2003
Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteersCelia J A Morgan, Ali Mofeez, Brigitta Brandner, et al.
Psychopharmacology|November 14, 2009
Decreases in recollective experience following acute alcohol: a dose-response studyJames A Bisby, Julie R Leitz, Celia J A Morgan, et al.
Brain : a Journal of Neurology|September 1, 1973
Central core disease or not? Observations on a family with a non-progressive myopathyJ A Morgan-Hughes, E M Brett, B D Lake, et al.
American Journal of Human Genetics|March 1, 1990
A new mitochondrial disease associated with mitochondrial DNA heteroplasmyI J Holt, A E Harding, R K Petty, et al.
Psychopharmacology|January 17, 2004
Ketamine impairs response inhibition and is positively reinforcing in healthy volunteers: a dose-response studyCelia J A Morgan, Ali Mofeez, Brigita Brandner, et al.
Brain : a Journal of Neurology|June 1, 1981
Alterations in the number and affinity of junctional acetylcholine receptors in a myopathy with tubular aggregates. A newly recognized receptor defectJ A Morgan-Hughes, B R Lecky, D N Landon, et al.
Pageof 30

Showing results (121-130 of 297) with videos related to

Sort By:
Pageof 30
Neuropharmacology|January 18, 2018
Ketamine for the treatment of addiction: Evidence and potential mechanismsI Ivan Ezquerra-Romano, W Lawn, E Krupitsky, et al.
Lancet (London, England)|June 25, 1988
Deletions of muscle mitochondrial DNAI J Holt, J M Cooper, J A Morgan-Hughes, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|March 1, 1997
Nemaline myopathy: an unusual cause of ophthalmoparesisR A Wright, G T Plant, D N Landon, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 30, 2010
Cannabidiol attenuates the appetitive effects of Delta 9-tetrahydrocannabinol in humans smoking their chosen cannabisCelia J A Morgan, Tom P Freeman, Gráinne L Schafer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 7, 2003
Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteersCelia J A Morgan, Ali Mofeez, Brigitta Brandner, et al.
Psychopharmacology|November 14, 2009
Decreases in recollective experience following acute alcohol: a dose-response studyJames A Bisby, Julie R Leitz, Celia J A Morgan, et al.
Brain : a Journal of Neurology|September 1, 1973
Central core disease or not? Observations on a family with a non-progressive myopathyJ A Morgan-Hughes, E M Brett, B D Lake, et al.
American Journal of Human Genetics|March 1, 1990
A new mitochondrial disease associated with mitochondrial DNA heteroplasmyI J Holt, A E Harding, R K Petty, et al.
Psychopharmacology|January 17, 2004
Ketamine impairs response inhibition and is positively reinforcing in healthy volunteers: a dose-response studyCelia J A Morgan, Ali Mofeez, Brigita Brandner, et al.
Brain : a Journal of Neurology|June 1, 1981
Alterations in the number and affinity of junctional acetylcholine receptors in a myopathy with tubular aggregates. A newly recognized receptor defectJ A Morgan-Hughes, B R Lecky, D N Landon, et al.
Pageof 30